Outstanding Recoveries
- Home
- Outstanding Recoveries
Verdicts & Settlements
Since Milberg’s founding in 1965, the firm has recovered more than $50 billion for our clients while prompting meaningful changes in corporate governance.
Filter By
Select Practice Area
-
See More$1+ Billion Settlement – Merck & Co., Inc. Securities Litigation
In re Merck & Co., Inc. Securities Litigation, Nos. 05-1151 and 05-2367 (D.N.J.)Milberg served as Co-Lead Counsel in this federal securities fraud class action, and after more than 12 years of hard-fought litigation, ultimately obtained a combined settlement totaling $1.062 billion, the largest securities class action settlement ever against a pharmaceutical company. The Court described the settlement as “a settlement which is fair and just and which, in fact, is the best settlement which possibly could have been achieved in this case.” -
See More$400+ Million Settlement – Chantix (Varenicline) Products Liability Litigation
In re Chantix (Varenicline) Products Liability Litigation, MDL 2092 (U.S. District Court for the Northern District of Alabama, Southern Division)Milberg attorneys served as Co-Lead Counsel in the Chantix Coordination in New York State Court and court-appointed member of the Plaintiffs Steering Committee in the MDL in Alabama. -
See More$3.2 Billion Settlement – Tyco International Securities Litigation
In re Tyco International Ltd., Securities Litigation, MDL 1335 (D.N.H.)Milberg served as Co-Lead Counsel in this litigation, which involved federal securities claims against Tyco and its former CEO, CFO, general counsel, and certain former directors arising out of alleged insider trading and the overstatement of billions of dollars in income. In 2007, the court approved a $3.2 billion settlement. -
See More$600 Million Settlement – Lucent Technologies, Inc. Securities Litigation
In re Lucent Technologies, Inc. Securities Litigation, No. 00-621 (D.N.J.)Milberg served as Co-Lead Counsel in this securities action, which alleged that Lucent and its senior officers misrepresented the demand for Lucent products and improperly recognized hundreds of millions of dollars in revenues. The case settled for $600 million. -
See More$586 Million Settlement – Initial Public Offering Securities Litigation
In re Initial Public Offering Securities Litigation, No. 21-92 (S.D.N.Y.)Milberg represented investors in 310 securities class actions alleging a market manipulation scheme involving hundreds of initial public offerings and approximately 55 defendant investment banks. This scheme, plaintiffs alleged, significantly contributed to the high-tech “bubble” of the late 1990s and early 2000. In approving a $586 million settlement in 2009, the court described the law firms on the Plaintiffs’ Executive Committee as the “cream of the crop.”
